During the past decade, AZ Turnhout conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 8 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 6 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Turnhout" #1 sponsor was "Universitaire Ziekenhuizen KU Leuven" with 6 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "University Hospital, Antwerp" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Dafne Balemans" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Turnhout" #1 collaborator was "AZ Delta" with 4 trials as a collaborator, "AZ Sint-Jan AV" with 4 trials as a collaborator, "AZ Turnhout" with 4 trials as a collaborator, "University Hospital, Antwerp" with 4 trials as a collaborator and "Universiteit Antwerpen" with 3 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 77 trials.

According to Clinical.Site data, the most researched conditions in "AZ Turnhout" are "Breast Cancer" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Failed Back Surgery Syndrome" (2 trials), "Multiple Myeloma" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "AZ Turnhout" in a lesser frequency.

Most popular intervention types in "AZ Turnhout" are "Drug" (23 trials), "Other" (9 trials), "Device" (3 trials), "Diagnostic Test" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Daratumumab" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials) and "780G" (1 trials). Other intervention names were less common.

The vast majority of trials in "AZ Turnhout" are 39 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "AZ Turnhout". undefined are not yet recruiting, 17 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in AZ Turnhout, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Turnhout, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".